top of page
The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Washington in 2022.
Economic
Output
$26.7B
Direct Jobs Supported by the Industry
21,984
Total Jobs Supported
81,122
State Total Vendor Relationships
950
State Total Vendor Spending
$874,422,674
Clinical
Trials
847
Investments at Clinical Trial Sites
$295.7M
Clinical Trial Participants
25,267
Total Economic Impact of Clinical Trial Sites
$783.5M
bottom of page